Skip to main content
Fig. 4 | BMC Neuroscience

Fig. 4

From: Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben

Fig. 4

Overview of representative whole body PET images of a 18F-florbetaben and b 18F-flutemetamol in AD transgenic mouse. 18F-flutemetamol PET imaging showed much more intense uptake in the bowel and bladder than did 18F-florbetaben. Each row represents a representative PET image of the study group in sagittal view (middle column) and axial view (right column). Color scale bar represents (from black to white) 0–30% ID/g (percentage of injected dose per g) in both 18F-florbetaben and 18F-flutemetamol image

Back to article page

BMC Neuroscience

ISSN: 1471-2202

Contact us